Literature DB >> 2158347

Site-directed mutagenesis of the hole-forming toxin aerolysin: studies on the roles of histidines in receptor binding and oligomerization of the monomer.

M J Green1, J T Buckley.   

Abstract

The six histidines of the channel-forming protein aerolysin have been replaced one at a time with asparagine by site-directed mutagenesis, and each of the modified proteins has been purified. Three proteins had the same hemolytic activity as native toxin, but the others, those changed at His107, His132, or His332, were less able to disrupt both human and rat erythrocytes. The largest reduction in activity, more than 100-fold, was observed with the His132 mutant protein. Studies with radioiodinated samples showed that it had approximately the same affinity as native aerolysin for the rat erythrocyte receptor. However, once bound to either rat or human erythrocytes, it was much less able to carry out the next essential step in hole formation, aggregation to form a stable oligomer. Aggregation was also reduced by replacing His107, but the contrast with native aerolysin and the effect on hemolytic activity were less pronounced. The protein modified at His332 behaved in a different way from those substituted at positions 107 and 132. Its affinity for the rat erythrocyte receptor was considerably lower than the affinity of the wild-type protein, but when bound it appeared to aggregate normally. The results suggest that His132 and perhaps His107 are involved in the aggregation of aerolysin whereas His332 may be at or near the receptor binding site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158347     DOI: 10.1021/bi00460a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Preliminary crystallographic analysis of two oligomerization-deficient mutants of the aerolysin toxin, H132D and H132N, in their proteolyzed forms.

Authors:  Lucile Pernot; Marc Schiltz; F Gisou van der Goot
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-11-26

2.  Identification of functional domains of Clostridium septicum alpha toxin.

Authors:  Jody A Melton-Witt; Lori M Bentsen; Rodney K Tweten
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

3.  Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila.

Authors:  M R Ferguson; X J Xu; C W Houston; J W Peterson; D H Coppenhaver; V L Popov; A K Chopra
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Aerolysin and pertussis toxin share a common receptor-binding domain.

Authors:  J Rossjohn; J T Buckley; B Hazes; A G Murzin; R J Read; M W Parker
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

5.  Homology between the seed cytolysin enterolobin and bacterial aerolysins.

Authors:  M V Sousa; M Richardson; W Fontes; L Morhy
Journal:  J Protein Chem       Date:  1994-11

6.  Subunit stoichiometry of staphylococcal alpha-hemolysin in crystals and on membranes: a heptameric transmembrane pore.

Authors:  J E Gouaux; O Braha; M R Hobaugh; L Song; S Cheley; C Shustak; H Bayley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  Amino acids in pneumolysin important for hemolytic activity identified by random mutagenesis.

Authors:  J Hill; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Pseudomonas aeruginosa cytotoxin: the Asp197-Gly-Asp-Tyr-His-Tyr-His-Tyr202 containing loop is critical for plasma membrane binding.

Authors:  M Struckmeier; G Xiong; F Lutz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-03       Impact factor: 3.000

9.  Pore formation by the sea anemone cytolysin equinatoxin II in red blood cells and model lipid membranes.

Authors:  G Belmonte; C Pederzolli; P Macek; G Menestrina
Journal:  J Membr Biol       Date:  1993-01       Impact factor: 1.843

10.  Role of a cytotoxic enterotoxin in Aeromonas-mediated infections: development of transposon and isogenic mutants.

Authors:  X J Xu; M R Ferguson; V L Popov; C W Houston; J W Peterson; A K Chopra
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.